Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Operating Leases (2020 - 2025)

Inspire Medical Systems (INSP) has disclosed Operating Leases for 6 consecutive years, with $32.2 million as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 1.14% to $32.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.2 million through Dec 2025, up 1.14% year-over-year, with the annual reading at $32.2 million for FY2025, 1.14% up from the prior year.
  • Operating Leases hit $32.2 million in Q4 2025 for Inspire Medical Systems, up from $30.3 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $32.2 million in Q4 2025 to a low of $6.0 million in Q1 2021.
  • Historically, Operating Leases has averaged $18.5 million across 5 years, with a median of $23.3 million in 2023.
  • Biggest five-year swings in Operating Leases: dropped 15.99% in 2023 and later surged 240.99% in 2024.
  • Year by year, Operating Leases stood at $8.8 million in 2021, then decreased by 14.32% to $7.5 million in 2022, then skyrocketed by 229.7% to $24.8 million in 2023, then grew by 27.96% to $31.8 million in 2024, then rose by 1.14% to $32.2 million in 2025.
  • Business Quant data shows Operating Leases for INSP at $32.2 million in Q4 2025, $30.3 million in Q3 2025, and $30.9 million in Q2 2025.